(HIT) solutions expands in the United States, the Company also
participates in health IT globally. Wall Street continues to remain bullish on health information technology, and biotech, both of which are the subject of the Company's portfolio of
U.S. and foreign patents. Through its wholly owned subsidiary, MyMedicalRecords, Inc., the Company currently has health IT patents issued, pending and/or applied for in the
United States and 11 other countries or regional authorities of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, China, South
Korea, Israel and Europe. In the U.S., MMR currently has 13 issued health IT patents including U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045;
8,321,240; 8,498,883; 8,626,532, 8,645,161; 8,725,537; 8,768,725 and 8,775,212, as well as additional applications and continuation applications pertaining to Personal Health
Records, Patient Portals and Electronic Health Records. MMR is also beginning to capture opportunities in the Middle East starting in Kuwait, where a higher percentage of the
population is comprised of Expats and health information technology is also driven by medical tourism. Additionally, MMR has a large and growing portfolio of biotech patents which
it acquired through the Company's 2009 reverse merger with Favrille, Inc. These assets have particular utility for the treatment of B-cell mediated cancers such as Non-Hodgkin's
lymphoma and other diseases of the immune system, and include patient samples owned and/or controlled by the Company. To date, MMR has six biotechnology patents issued by
the United States Patent and Trademark Office, additional patents issued in Australia, South Korea, Mexico, Singapore, Hong Kong, Japan and throughout Europe, and patents
pending in various other countries of commercial interest.
In 2015, the Company also expects to benefit from the growth in Telemedicine and smartphone usage in healthcare, which requires connectivity to patients through a Personal
Health Record. MMR already has connectivity to Telemedicine systems built into the Company's PHR platform.
About MMRGlobal
MMRGlobal, Inc., through its wholly-owned subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe
deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations
and affinity groups. The
.
3/
Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation, intellectual property licenses, intellectual property enforcement actions,
infringement claims or litigation, and future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such
forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or
from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility,"
"potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of
these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be
considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties,
including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal
and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees,
competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to:
unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to
maintain, develop, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of
milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees;
the risk MMR's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and
installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions;
changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and
initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining
and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation
matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's filings with the Securities and Exchange
Commission. Additional information is set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2014. MMR is providing this information as of the
date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of
new information, future events or otherwise.
###
CONTACT:
Michael Selsman
Public Communications Co.
